Epilepsy, treatment derivatives

Historically the only melanocortin peptide to be used clinically is the parent hormone from which all these peptides are derived from namely ACTH (see above). It has also been used in the treatment infantile spasms for epilepsy, where it is administered as an intramuscular injection only over a 2-12 weeks period. Obvious side effects include weight gain, puffy face, high blood pressure and an increased risk of infection and should never be administered to patients with diabetics, renal or heart failure. ACTH is also used as a stimulation test to measure adrenal cortex activity, i.e. production of cortisol and is used to ascertain whether someone has Addison s disease. 

Valproic acid (dipropylacetic acid) is a single branched chain carboxylic acid that is structurally unlike any of the other drugs used in the treatment of bipolar disorder or epilepsy. The amide derivative, valproamide, is available in Europe as a more potent form of valproate. Valproate was first developed in Erance as an antiepileptic agent in 1963. As an antiepileptic agent, it was shown to be active against a variety of epilepsies without causing marked sedation. 

An interesting example of biocatalysis and chemical catalysis is the synthesis of a derivative of y-aminobutyric acid (GABA) that is an inhibitor for the treatment of neuropathic pain and epilepsy (Scheme 10.4). The key intermediate is a racemic mixture of cis- and trons-diastereoisomer esters obtained by a hydrogenation following a Horner-Emmons reaction. The enzymatic hydrolysis of both diaste-reoisomers, catalyzed by Candida antarctica lipase type B (CALB), yields the corresponding acid intermediate of the GABA derivative. It is of note that both cis- and trans-diastereoisomers of the desired enantiomer of the acid intermediate can be converted into the final product in the downstream chemistry [10]. 

GABA analogs are used in the treatment of epilepsy and hypertension. Levels of GABA can also be increased by administering inhibitors of the GABA-degrading enzyme GABA aminotransferase. Another important neuro-transmitter, serotonin, is derived from tryptophan in a two-step pathway. 

Cyclopropyl-(3-amino acid derivatives, (V), having high binding affinities to the a28 subunit of a calcium channel were prepared by Schwarz (4) and used in the treatment of epilepsy. 

Oxo-piperidinyl-, (VI), and 2-oxo-azepanyl alkanoic acid derivatives prepared by Michel (5) were effective in the treatment of epilepsy and related seizure disorders. 

Ethnopharmacological research on natural products can contribute to the discovery of new active compounds with novel structures which may serve as leads to the development of new antiepileptic drugs. An example is the isolation of the active alkaloid piperine from Piper nigrum L. which is one of the component herbs of an ancient Chinese medicine used for the treatment of epilepsy. Its structural modifications resulted in the synthesis of seven derivatives including antiepilepserine which was found to be more potent than the parent compound with fewer side effects and it has been used as an antiepileptic drug [10-12]. 

N-unsubstituted sulphamates of the type 244 have been prepared by the reaction of the appropriate alcohol with sodium hydride in DMF with sulphamoyl chloride at 0-5 °C248. The compounds are reported to have anticonvulsant activity and are considered to be potential agents for the treatment of epilepsy. In addition, carbonic anhydrase activity was reported for the compounds and they are considered to be useful in the treatment of glaucoma. A series of 8a-substituted ergoline derivatives (245) were shown to have anti-Parkinson activity and inhibited prolactim secretion249. 

In the early 1960s, there was a near-simultaneous introduction of carbamazepine and valproic acid and its derivatives, as new treatments for epilepsy. Although in 1882 Beverly S. Burton, an American working in Europe, had prepared valproic acid, its antiepileptic utility was not appreciated until this was serendipitously discovered 65 years later by Meunier in France. Carbamazepine was first synthesized in 1960, in the United States by Schindler — who, a decade earlier, had patented the stmcturally closely related imipramine and it was found to have antiepileptic properties. When concurrent remedial effects on mood and behaviour were noted with both carbamazepine and valproic acid in the very early epilepsy trials, both drags were soon appropriated by psychiatrists, first by Lambert in France (1966), using the amide derivative of valproic acid. 

There are many derivatives of barbituric acid. The first to the market was diethylbarbituric acid, which is also known as barbital, malonal, or gardenal. Phenobarbital was introduced by Bayer Pharmaceuticals in 1912 and is used currently for the treatment of epilepsy. In 1926, the effect of phenobarbital on cerebral circulation was studied. During the twentieth century, more than 2500 barbiturates were synthesized, 50 of which were eventually employed clinically. ... 

Imides are diacyl derivatives of ammonia or primary amines. The reaction is similar in its scope and mechanism to the acetylation of aniline or 1,4-phenylene-diamine presented in Experiments [23A] and [23B], As illustrated in the present experiment, cyclic anhydrides produce cyclic imides. Cyclic anhydrides are prepared in Experiments [25A] and [25B], Derivatives of imides have been suggested for use in the treatment of arthritis, tuberculosis, and epilepsy. Several also have been found to be growth stimulants. Imide-based polymers are used in many applications, including fire-resistant woven fabrics. The N-phenyl-maleimide prepared in this experiment is also a good dienophile in the Diels-Alder reaction (see Experiments [14] and [15]), and in fact has been used as a reagent to characterize 1,3 dienes. 

The following three derivatives of succinimide are anticonvulsants that have found use in the treatment of epilepsy, particularly petit mal seizures. 

As mentioned, GABA is an important neural transmitter and deficiencies in GABA are associated with diseases that exhibit neuromuscular dysfunction such as epilepsy, Huntington s disease and Parkinson s disease. S-Aminopentanoic acid (S-aminovaleric acid, DAVA) is also a neurotransmitter and used for treatment of neuromuscular disease. In at least one study, 3-alkyl-4-aminobutanoic acid derivatives were shown to be in vitro activators of f glutamic acid decarboxylase and they showed anti-convulsant activity. ... 

---